To that end, we evaluated both, intracellular and extracellular, PAD2 and PAD4 activities in PBMC and PMN cultures, as well as in cell-free synovial fluid from RA patients via PAD inhibition with AFM-30a, GSK199, and BB-Cl-amidine. This evidence concerns the gene PADI4 and rheumatoid arthritis.